TOP NEWS

Xencor Launches $110M Public Offering

Monrovia-based biotechnology developer Xencor has launched a public offering of its common stock, with the aim of raising approximately $110M in funding, the company said on Wednesday. The publicly traded biotechnology developer--which trades on the NASDAQ as XNCR--said it has priced the offering at $24.000 per share. The company said the new funding will go towards working capital and general corporate purposes, including investing in its pipeline and lead compoound.


LATEST HEADLINES

More Headlines

BROWSE ISSUES